Indefinite Delivery Contract SPE2DR25D9326

The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide.

The contract, which is valid through November 2026, covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This IDC enables the DLA to issue firm fixed-price delivery orders for these pharmaceutical items to support the medical supply needs of Department of Defense (DoD) healthcare sites globally, including normal day-to-day operations, planned and unplanned contingencies, Prime Vendor Readiness, and War Readiness Materiel requirements. The contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its small business status to secure this direct federal award.